Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.69%) to 9100.77, DAX +1.12% to 24192.50, CAC40 +0.97% to 7709.32, STOXX 600 +0.92% to 546.05

Aug 07 ,2025

  • Synopsis:

    • European equity markets ended mostly firmer, with pan-European indices closing just off best levels. Austria +2.5%, Greece +1.4% and Germany +1.0% led the outperformers, while the FTSE100 (0.7%), Norway (0.3%) and Finland (0.1%) were the main laggards.

    • Markets welcoming Trump's carve-out from looming 100% tariff on semiconductors, which will exclude companies building in US or have made investment commitments. However, some details lacking ahead of formal announcement, including extent of US investment that will qualify companies for tariff relief. As foreshadowed, President Trump imposed additional 25% rate on India over its purchases of Russian crude (taking total tariff to 50%). Also did not rule out secondary sanctions on China over its Russian crude buys.

    • In geopolitical news, Putin aide confirmed Trump would meet Putin in coming days in bid to end Ukraine war.

    • Macro focus in Europe on BoE policy update. Bank cut rates to 4% as expected but opened door to pause in easing with a tight 5-4 vote. Markets now discount no further cuts in 2025. ECB bulletin highlighted easing inflationary pressures and softer wage growth. Data includes weak German industrial production and narrower-than-expected trade data. Halifax UK house price data close to expectations with modest increase in July.

    • Amidst a busy earnings calendar, DACH names kicked off the session, including Siemens AG (SIE.GR), Merck KGaA (MRK.GR), Rheinmetall (RHM.GR), Allianz (ALV.GR), SAF-HOLLAND (SFQ.GR), Henkel (HEN3.GR), Zurich Insurance Group (ZURN.SW), Swisscom (SCMN.SW) and Sandoz Group (SDZ.SW) among several others. In the UK, InterContinental Hotels Group, InterContinental Hotels Group (IHG.LN), WPP Group (WPP.LN), Deliveroo (ROO.LN), Hikma Pharmaceuticals (HIK.LN) and Spectris (SXS.LN) issued their most recent earnings. Out of the Nordics, shares in Maersk traded notably higher on the back of its Q2 numbers and raised FY25 guidance. In the Benelux region, SBM Offshore (SBMO.NA) and KBC Group (KBC.BB) issued their earnings updates. In other corporate developments, shares in Novo Nordisk (NOVO.B.DC) rose by as much as ~ +13% following the release of Eli Lilly's trial results.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Autos & Parts +1.94%, Travel & Leisure +1.78%, Technology +1.72%, Chemicals +1.71%, Construct & Mtls +1.64%, Insurance +1.60%, Basic Resources +1.57%, Banks +1.43%, Health Care +1.35%, Food & Beverage +1.18%, Retail +1.10%, Financial Svcs +1.09%

      • Underperformers

        • Telecom (1.99%), Oil & Gas (1.32%), Utilities (0.70%), Real Estate(0.05%), Media +0.44%, Persnl & HHold Goods +0.68%, Ind Goods & Svcs +0.77%

    • Macro/Peripheral markets:

      • Central Banks

        • ECB achieves 2% inflation but faces Euro zone disparities (Bloomberg)

        • Bank of England cuts interest rates to 4%, the lowest level in two years (BBC)

      • Geopolitics

        • Trump holds talks with Putin and Zelenskyy to address Ukraine conflict (Reuters)

        • Trump imposes 39% tariff on Swiss exports, straining trade relations (Bloomberg, Reuters)

        • Kremlin confirms Trump-Putin meeting 'in the coming days' (Politico)

      • UK

        • UK house prices rise 2.4% in July (Halifax)

        • UK private equity dealmakers decline amid tax crackdown (FT)

        • UK launches key offshore wind auction for 2030 goals (Bloomberg)

        • Mortgage rates drop in sign that crisis may be over (Times)

      • Germany

        • German trade surplus down to €14.9B in June (DeStatis)

        • German industrial production down by 1.9% in June (DeStatis)

      • Italy

        • No design against govt magistrates' union tells Meloni (Ansa)

      • Spain

        • Spain shuns US F-35 jets as tensions grow with Washington (FT)

    • Company news:

      • Notable Gainers

        • +30.2% EPWN.LN (Epwin Group £1.19, +0.28) -- Laumann makes recommended cash acquisition offer for Epwin Group at 120p/share

        • +13.2% RBI.AV (Raiffeisen Bank International €28.20, +3.28) -- UBS upgrade

        • +11.9% SDZ.SW (Sandoz Group CHF50.62, +5.38) -- H1 earnings

        • +11.8% VANQ.LN (Vanquis Banking Group £1.15, +0.12) -- H1 earnings

        • +11.3% DEZ.GR (Deutz AG €8.39, +0.86) -- Q2 earnings

        • +10.8% LNZ.AV (Lenzing €27.20, +2.65) -- H1 earnings

        • +8.6% HBR.LN (Harbour Energy £2.22, +0.18) -- H1 earnings

        • +8.1% IP.IM (Interpump Group €40.26, +3.02) -- Q2 earnings; Mediobanca upgrade

        • +7.9% FFARM.NA (ForFarmers €4.19, +0.31) -- H1 earnings

        • +7.8% WEW.GR (Westwing Group €10.65, +0.77) -- Q2 earnings

        • +7.7% DOV.IM (doValue €2.63, +0.19) -- H1 earnings

        • +7.4% CRH.LN (CRH plc £79.04, +5.46) -- Q2 earnings

        • +7.0% SDG.LN (Sanderson Design Group £0.54, +0.04) -- trading update

        • +6.8% S92.GR (SMA Solar Technology €20.54, +1.30) -- H1 earnings

        • +6.7% NOVO.B.DC (Novo Nordisk DKK308.85, +19.35) -- Eli Lilly announcespositive topline results from the Phase 3 ATTAIN-1 trial evaluating orforglipron, meets primary endpoin

        • +6.2% IHG.LN (InterContinental Hotels Group £92.16, +5.34) -- H1 earnings

        • +5.7% KBC.BB (KBC Group €98.42, +5.34) -- Q2 earnings

        • +5.1% MAERSK.B.DC (Maersk DKK13,805.00, +675.00) -- Q2 earnings; initiates second DKK7.2B phase of DKK 14.4B share buy-back program

        • +5.1% NOD.NO (Nordic Semiconductor NOK135.90, +6.60) -- assumed buy at Carnegie Securities

        • +5.1% SQN.SW (Swissquote Group Holding CHF569.00, +27.50) -- initiated buy at Deutsche Bank

        • +4.6% FRA.GR (Fraport €74.35, +3.25) -- Jefferies upgrade

        • +4.1% ALV.GR (Allianz €366.90, +14.40) -- Q2 earnings

        • +3.9% TOM.NO (Tomra Systems NOK150.80, +5.70) -- Arctic Securities upgrade

        • +3.7% SRP.LN (Serco Group £2.17, +0.08) -- H1 earnings

        • +3.5% AVOL.SW (Avolta CHF44.06, +1.48) -- BNP Paribas Exane upgrade

        • +2.8% VLA.FP (Valneva €3.57, +0.10) -- removal of fda-recommended pause on use of Chikungunya vaccine IXCHIQ in elderly

        • +2.5% UTDI.GR (United Internet €25.82, +0.62) -- Q2 earnings

        • +2.5% WBD.IM (Webuild €4.19, +0.10) -- contract

        • +2.2% CLAS.B.SS (Clas Ohlson SEK352.00, +7.60) -- Jul sales

        • +2.0% LIKE.LN (Likewise Group £0.26, +0.01) -- raises c.£1.4M from 5.5M shares equity subscription with Onward Opportunities at 25p per share

        • +1.6% NORSE.NO (Norse Atlantic NOK9.26, +0.15) -- Jul traffic

      • Notable Decliners

        • -14.4% VBK.GR (Verbio €9.98, -1.68) -- prelim EBITDA for 2024/2025 financial year below forecast

        • -13.9% HARVIA.FH (Harvia €43.15, -6.95) -- Q2 earnings

        • -13.6% MGAM.LN (Morgan Advanced Materials £1.95, -0.31) -- H1 earnings

        • -12.4% G5EN.SS (G5 Entertainment SEK91.10, -12.90) -- Q2 earnings

        • -11.2% OPTOMED.FH (Optomed €4.04, -0.51) -- Q2 earnings

        • -10.1% GAM.SW (Gam Holding CHF0.09, -0.01) -- H1 earnings

        • -8.9% AFX.GR (Carl Zeiss Meditec €43.62, -4.26) -- 9M earnings

        • -7.1% HAYPP.SS (Haypp Group SEK136.60, -10.40) -- Q2 earnings

        • -7.1% RHM.GR (Rheinmetall €1,656.00, -127.50) -- Q2 earnings

        • -6.6% HIK.LN (Hikma Pharmaceuticals £17.59, -1.25) -- H1 earnings

        • -5.9% FNTN.GR (Freenet €27.04, -1.70) -- H1 earnings

        • -5.5% SBMO.NA (SBM Offshore €21.48, -1.26) -- H1 earnings

        • -4.9% DTE.GR (Deutsche Telekom €29.80, -1.53) -- Q2 earnings

        • -4.3% SGL.GR (SGL Carbon €3.45, -0.16) -- H1 earnings

        • -4.1% DETEC.FH (Detection Technology €10.60, -0.45) -- Q2 earnings

        • -3.8% RSL2.GR (R. Stahl €17.70, -0.70) -- Q2 earnings

        • -3.7% CAPMAN.FH (Capman €1.86, -0.07) -- H1 earnings

        • -3.6% PDX.SS (Paradox Interactive SEK162.60, -6.10) -- H1 earnings

        • -3.3% G24.GR (Scout24 €115.30, -3.90) -- Q2 earnings

        • -2.8% SBO.NO (Selvaag Bolig NOK36.70, -1.05) -- Q2 earnings

        • -2.6% WPP.LN (WPP Group £3.92, -0.10) -- H1 earnings

        • -1.5% GLEN.LN (Glencore £2.81, -0.04) -- Goldman Sachs downgrade

    • EU companies reporting tomorrow:

      • Earnings:

        • Austria: Oesterreichische Post (POST.AV), Rosenbauer International (ROS.AV),

        • Benelux: NN Group (NN.NA), Lotus Bakeries (LOTB.BB), bpost (BPOST.BB)

        • Finland: Bittium (BITTI.FH), SRV Group (SRV1V.FH), Glaston (GLA1V.FH)

        • Germany: Munich Re (MUV2.GR), EnBW Energie Baden-Wuerttemberg (EBK.GR), Deutsche Wohnen (DWNI.GR), RTL Group (RRTL.GR), Bechtle (BC8.GR), Eckert & Ziegler Strahlen- und Medizintechnik (EUZ.GR), Jungheinrich (JUN3.GR), OVB Holding (O4B.GR), Himalaya Shipping (J1X.GR), Fabasoft (FAA.GR), Knaus Tabbert (KTA.GR), PWO (PWO.GR), Data Modul (DAM.GR), 4SC (VSC.GR)

        • Italy: The Italian Sea Group (TISG.IM), Emak (EM.IM)

        • Other: MOL Hungarian Oil & Gas (MOL.HB)

        • Sweden: RaySearch Laboratories (RAY.B.SS), Alcadon Group (ALCA.SS)

        • Switzerland: Mobimo Holding (MOBN.SW)

        • UK/Ireland: TBC Bank Group (TBCG.LN), Stelrad Group (SRAD.LN), FBD Holdings (EG7.ID)

  • Data:

    • Economics:

      • Switzerland Jul Unemployment Rate 2.7% vs consensus 2.8% and prior 2.7%

      • Germany

        • Jun Trade Balance €14.9B vs consensus €17.8B and prior revised €18.6B from €18.4B

        • Jun Industrial Production (1.9%) m/m vs consensus (0.4%) and prior revised (0.1%) from +1.2%

      • Norway Jun Manufacturing Production (0.1%) m/m vs consensus (0.5%) and prior revised (1.6%) from (1.7%)

      • Sweden Jul preliminary CPI +0.8% y/y vs consensus +0.9% and prior +0.7%

      • UK Jul Halifax House Price Index +2.4% y/y vs consensus +2.2% and prior revised +2.7% from +2.5%

      • France Jun Trade Balance (€7.6B) vs consensus (€7.5B) and prior revised (€7.6B) from (€7.8B)

    • Markets:

      • WTI Crude (Sep 25): ($0.17) or (0.26%) to $64.18

      • €-$ (0.0022) or (0.19%) to 1.1639

      • £-$ +0.0064 or +0.48% to 1.3420

      • €-£ (0.0059) to 0.8671

      • S&P 500 (0.12%)

        • Performance year-to-date

        • FTSE 100: +11.35%

        • DAX: +21.51%

        • CAC: +4.45%

        • MIB: +21.10%

        • Stoxx 600: +7.57%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE